Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05713357

Repeated Endocardial Mapping for Efficacy Assessment After Catheter Ablation for Ischemic Ventricular Tachycardia

Conditions: Ischemic Cardiomyopathy, Ventricular Tachycardia

Sex: All
Ages: 18 Years – 85 Years
Enrollment: 20
Sponsor: University Medical Centre Ljubljana

Summary

Patients with ischemic ventricular tachycardia (VT) are frequently treated with radiofrequency catheter ablation. The efficacy of catheter ablation is limited for various reasons; one of those being incomplete myocardial and inhomogenous scar tissue damage due to suboptimal ablation lesions.The aim of our study is to reassess initially ablated endocardial areas in a repeated mapping procedure. Initial lesion parameters will be studied in areas with conduction recovery at repeated mapping procedure. Also, VT inducibility will be correlated to the extent and characteristics of areas with recovered conduction.

Eligibility Criteria

Inclusion Criteria:ischemic heart disease,sustained ventricular tachycardia,implanted (or scheduled for implantation) cardiac electrical device with ability to record and store intracardiac electrogramsExclusion Criteria:nonischemic cardiomyopathy,need for epicardial access to the substrate for treatment of ventricular tachycardia,any severe acute organ damage beyond cardiomyopathy that could potentialy omit remapping procedure after 3 months,any terminal disease with expected survival of less than one year

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05713357). StuddyBuddy aggregates publicly available trial information.